Aromatase inhibitors and fracture prevention - do 2017 guidelines work in real world?
{{output}}
Objectives: Aromatase inhibitor induced bone loss (AIBL) is a recognised adverse event with resultant increase in fracture risk. We aimed to determine the real-world impact of the 2017 consensus guidelines on AIBL and see if it i... ...
